… test, whether or not it is in conformance with this statement. Clinicians also are advised to
take notice of the date this statement was adopted, and to consider other medical and scientific …

… However, as with more extensive genome-wide data, or genomic risk scores, different
levels … is simply stated in association with a variant, the validity of that association cannot be …

… Association scientific statement, 2 so we present only a few examples here. Epigenome-wide
association … sites, called CpG sites, across the genome all at once. This makes it possible …

… studies (GWASs) and whole-genome sequencing have led to the discovery of novel genomic
determinants of CVDs, and we focus on these findings. Unlike candidate gene association …

… Our working group has built upon the solid foundation of the original policy statement, … We
revise the germline variant classification recommendations to align with ACMG/Association for …

… test, whether or not it is in conformance with this statement. Clinicians also are advised to
take notice of the date this statement was adopted, and to consider other medical and scientific …

… genomic testing, oncologists and other health care providers should continue to be guided
by the criteria set out in ASCO’s 2003 statement … Tuma RS: Genome-wide association studies …

… to genomic healthcare. The document identifies important ethical considerations for those
developing genetic healthcare … Interpretive statement 8.3 requires nurses to examine and …

… extends to both medical genomics and medical practice in general. Next-generation genomic
testing, including multigene panels, exome sequencing (ES), and genome sequencing (GS…

… phenotype is profoundly influenced by the pattern of genomic aberrations withinthetumor.…
More comprehensive tumor analysis (eg, whole-exome or whole-genome sequencing) will …